Memorial Sloan-Kettering Cancer Center Researcher Yields New Findings on Multiple Myeloma (Bendamustine Bridging Versus Standard of Care Chemotherapy on Toxicity Profile for Multiple Myeloma Patients Undergoing CAR T Cell Therapy)

Press/Media

Period20 Dec 2023

Media coverage

1

Media coverage

  • TitleMemorial Sloan-Kettering Cancer Center Researcher Yields New Findings on Multiple Myeloma (Bendamustine Bridging Versus Standard of Care Chemotherapy on Toxicity Profile for Multiple Myeloma Patients Undergoing CAR T Cell Therapy)
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date20/12/23
    PersonsSundar Jagannath